---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008808"
form_type: "8-K"
ticker: "ELTP"
cik: "0001053369"
company_name: "ELITE PHARMACEUTICALS INC /NV/"
filed_at: "2025-03-03T23:59:59+00:00"
generated_at: "2026-05-25T16:46:05.271364+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Elite Pharmaceuticals ships first product from new FDA-approved expanded campus

## Summary
- First lot of finished product shipped from new facility at 144 Ludlow Avenue, Northvale, NJ.
- New packaging line runs at ~120 bottles per minute, adding packaging, inventory and warehouse space.
- Expansion converts existing packaging space into additional manufacturing suites, boosting production capacity.
- Company says new facility positions it to meet projected packaging demand for at least the next five years.

## SEC filing metadata
- accession: 0001493152-25-008808
- form_type: 8-K
- ticker: ELTP
- cik: 0001053369
- company_name: ELITE PHARMACEUTICALS INC /NV/
- filed_at: 2025-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1053369/000149315225008808/0001493152-25-008808-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1053369/000149315225008808/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008808
- JSON: https://secwatch.observer/filing/0001493152-25-008808.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008808.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.